Mary McKillop Institute for Health Research, Australian Catholic University, Melbourne, Australia.
Centre for Metabolic Bone Diseases, University of Sheffield, Sheffield, UK.
Osteoporos Int. 2023 Mar;34(3):489-499. doi: 10.1007/s00198-022-06629-y. Epub 2022 Dec 16.
The incidence of hip and major osteoporotic fracture was increased in patients with primary hyperparathyroidism even in patients not referred for parathyroidectomy. The risk of death was also increased which attenuated an effect on fracture probabilities. The findings argue for widening the indications for parathyroidectomy in mild primary hyperparathyroidism.
Primary hyperparathyroidism (PHPT) is associated with an increase in the risk of fracture. In FRAX, the increase in risk is assumed to be mediated by low bone mineral density (BMD). However, the risk of death is also increased and its effect on fracture probability is not known.
The aim of this study was to determine whether PHPT affects hip fracture and major osteoporotic fracture risk independently of bone mineral density (BMD) and whether this and any increase in mortality affects the assessment of fracture probability.
A register-based survey of patients with PHPT and matched controls in Denmark were identified from hospital registers. The incidence of death, hip fracture, and major osteoporotic fracture were determined for computing fracture probabilities excluding time after parathyroidectomy. The gradient of risk for fracture for differences in BMD was determined in a subset of patients and in BMD controls. The severity of disease was based on serum calcium and parathyroid hormone levels.
We identified 6884 patients with biochemically confirmed PHPT and 68,665 matched population controls. On follow-up, excluding time after parathyroidectomy in those undergoing surgery, patients with PHPT had a higher risk of death (+52%), hip fracture (+48%), and major osteoporotic fracture (+36%) than population controls. At any given age, average 10-year probabilities of fracture were higher in patients with PHPT than population controls. The gradient of fracture risk with differences in BMD was similar in cases and controls. Results were similar when confined to patients not undergoing parathyroidectomy. Fracture probability decreased with the severity of disease due to an increase in mortality rather than fracture risk.
The risk of hip and other major osteoporotic fracture is increased in PHPT irrespective of the disease severity. Fracture probability was attenuated due to the competing effect of mortality. The increased fracture risk in patients treated conservatively argues for widening the indications for parathyroidectomy in mild PHPT.
本研究旨在确定原发性甲状旁腺功能亢进症(PHPT)是否独立于骨密度(BMD)影响髋部骨折和主要骨质疏松性骨折风险,以及这种情况和任何死亡率的增加是否会影响骨折概率的评估。
从丹麦的医院登记处确定了 PHPT 患者和匹配对照的基于登记的调查。确定了死亡、髋部骨折和主要骨质疏松性骨折的发生率,以计算排除甲状旁腺切除术后时间的骨折概率。在患者亚组和 BMD 对照组中确定了 BMD 差异的骨折风险梯度。疾病的严重程度基于血清钙和甲状旁腺激素水平。
我们确定了 6884 例经生化证实的 PHPT 患者和 68665 名匹配的人群对照。在随访期间,排除接受手术的患者手术后时间,PHPT 患者的死亡风险(增加 52%)、髋部骨折风险(增加 48%)和主要骨质疏松性骨折风险(增加 36%)高于人群对照。在任何给定的年龄,PHPT 患者的平均 10 年骨折概率均高于人群对照。病例和对照组之间的骨折风险梯度相似。当仅限于未接受甲状旁腺切除术的患者时,结果相似。骨折概率随着疾病严重程度的增加而降低,这是由于死亡率的增加而不是骨折风险的增加。
PHPT 患者的髋部和其他主要骨质疏松性骨折风险增加,无论疾病严重程度如何。骨折概率因死亡率的竞争效应而减弱。接受保守治疗的患者骨折风险增加,这表明在轻度 PHPT 中扩大甲状旁腺切除术的适应证是合理的。